Wikipedia -WSS

Wikipedia

author：hotspot 2025-10-02 19:39:25 - browse：98

Intellia Therapeutics said Sunday that the first 10 patients to receive a CRISPR-based treatment for hereditary angioedema, a genetic disease, saw their swelling attacks — the condition’s hallmark symptom — virtually eliminated for an average of 20 months and counting.

The attacks were reduced by an average of 98%. One patient has remained attack-free for 26 months. Two patients who suffered particularly frequent attacks, experiencing 14 and 16.8 per month, respectively, have now gone more than 20 months since their last attack.

No patient has had an attack in the last 11 months of follow-up, according to the data presented at the European Academy of Allergy and Clinical Immunology Congress. All side effects were either grade 1 or 2 on a 5-grade scale.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Kansas bar where gunfire wounded 9 last month closes permanently

knowledge

WSS

Trump used to be more articulate. What could explain the change?

St. Louis police protesters begin picking up checks in $4.9 million settlement

As H5N1 spreads in cows, experts warn against drinking raw milk

HHS suspends federal funding for EcoHealth Alliance

Obesity drug from Roche shows promise in early study

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

Wikipedia

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Alkermes shareholders re

Free medical tuition alone isn't enough to close gaps in primary care

State Dept. review finds Biden bears some blame for Afghanistan failures

Feed a cold, starve a fever? Here’s what science says

Trump demands the U.S. pay no more for drugs than other countries … again

With heat waves through August, officials warn of health risks

Cancer drug shortages should be causing more outrage

NFL doctors' conflicts of interest could endanger players, report says

Medical records are filled with copy

How CRISPR works, explained in two minutes

explore

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Free medical tuition alone isn't enough to close gaps in primary care

Novo Nordisk testing Wegovy against alcohol

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

Lilly’s weekly insulin works as well as daily products, new studies show

hotspot

leisure time

knowledge

explore